Arthritis Program and Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
Arthritis Program and Krembil Research Institute, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Arthritis Care Res (Hoboken). 2019 Sep;71(9):1178-1185. doi: 10.1002/acr.23831. Epub 2019 Aug 3.
To evaluate rates of prescription opioid use among patients with presurgical knee, hip, and spine osteoarthritis (OA) and associations between use and sociodemographic and health status characteristics.
Participants were patients with presurgical, end-stage OA of the knee (n = 77), hip (n = 459), and spine (n = 168). Data were collected on current use of opioids and other pain medications, as well as measures of sociodemographic and health status variables and depression and pain (0-10 numeric rating scale). Rates of opioid use were calculated by sex, age, and surgical site. Multivariable logistic regression was used to examine associations between opioid use (sometimes/daily versus never) and other study variables.
The mean age of participants was 65.6 years; 55.5% were women, 15% of patients reported "sometimes" using opioids, and 15% reported "daily use." Use of opioids was highest among patients with spine OA (40%) and similar among patients with knee and hip OA (28% and 30%, respectively). Younger women (ages <65 years) reported the greatest use of opioids overall, particularly among patients with spine OA. From multivariable logistic regression, greater likelihood of opioid use was significantly associated with spine OA (versus knee OA), obesity, being a current or former smoker, higher symptomatic joint count, greater depressive symptoms, greater pain, and current use of other prescription pain medication.
Nearly one-third of patients with presurgical OA used prescription opioid medication. Given the questionable efficacy of opioids in OA and risk of adverse effects, higher opioid use among younger individuals and those with depressive symptoms is of concern and warrants further investigation.
评估膝关节、髋关节和脊柱骨关节炎(OA)术前患者处方阿片类药物的使用率,并研究使用情况与社会人口统计学和健康状况特征之间的关系。
研究对象为膝关节(n=77)、髋关节(n=459)和脊柱(n=168)术前终末期 OA 患者。收集了当前使用阿片类药物和其他止痛药的情况,以及社会人口统计学和健康状况变量以及抑郁和疼痛(0-10 数字评分量表)的测量值。按性别、年龄和手术部位计算阿片类药物使用率。多变量逻辑回归用于检验阿片类药物使用(有时/每日与从不)与其他研究变量之间的关联。
参与者的平均年龄为 65.6 岁;55.5%为女性,15%的患者报告“有时”使用阿片类药物,15%报告“每日使用”。脊柱 OA 患者的阿片类药物使用率最高(40%),膝关节和髋关节 OA 患者的使用率相似(分别为 28%和 30%)。年轻女性(年龄<65 岁)总体上报告阿片类药物使用率最高,尤其是脊柱 OA 患者。多变量逻辑回归显示,阿片类药物使用的可能性与脊柱 OA(与膝关节 OA 相比)、肥胖、当前或曾经吸烟、更多症状关节计数、更严重的抑郁症状、更严重的疼痛以及当前使用其他处方止痛药显著相关。
近三分之一的术前 OA 患者使用处方阿片类药物。鉴于阿片类药物在 OA 中的疗效存在疑问且存在不良反应风险,年轻患者和有抑郁症状患者的阿片类药物使用率较高令人担忧,需要进一步调查。